Shang Wang

Title: Innovations by Inventor Shang Wang

Introduction

Shang Wang is a notable inventor based in Lianyungang, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative solid pharmaceutical compositions. With a total of two patents to his name, Wang's work demonstrates a commitment to advancing medical science.

Latest Patents

Wang's latest patents include a solid pharmaceutical composition comprising a TLR7 agonist. This composition features the compound 2-butoxy-7-(4-(pyrrolidin-1-ylmethyl)benzyl)-5H-pyrrolo[3,2-d]pyrimidin-4-amine. It is noted for its excellent stability and dissolution properties, making it a valuable addition to pharmaceutical formulations. Another patent involves a solid pharmaceutical composition containing a 1,3,5-triazine derivative or a pharmaceutically acceptable salt thereof. This composition includes 4-(tert-butoxyamino)-6-(6-(trifluoromethyl)pyridin-2-yl)-N-(2-(trifluoromethyl)pyridin-4-yl)-1,3,5-triazine-2-amine. It is characterized by good stability, a fast dissolution rate, and high bioavailability, making it suitable for clinical production and use.

Career Highlights

Shang Wang has worked with prominent companies in the pharmaceutical industry, including Chia Tai Tianqing Pharmaceutical Group Co., Ltd. and Lianyungang Runzhong Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Wang has collaborated with notable colleagues such as Zhilin Chen and Yi Xu. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Shang Wang's contributions to pharmaceutical innovations through his patents reflect his dedication to improving medical treatments. His work continues to influence the industry and showcases the importance of innovation in healthcare.